NCCN Guidelines® Insights: Bladder cancer, version 2.2022: Featured updates to the NCCN Guidelines Journal Article


Authors: Flaig, T. W.; Spiess, P. E.; Abern, M.; Agarwal, N.; Bangs, R.; Boorjian, S. A.; Buyyounouski, M. K.; Chan, K.; Chang, S.; Friedlander, T.; Greenberg, R. E.; Guru, K. A.; Herr, H. W.; Hoffman-Censits, J.; Kishan, A.; Kundu, S.; Lele, S. M.; Mamtani, R.; Margulis, V.; Mian, O. Y.; Michalski, J.; Montgomery, J. S.; Nandagopal, L.; Pagliaro, L. C.; Parikh, M.; Patterson, A.; Plimack, E. R.; Pohar, K. S.; Preston, M. A.; Richards, K.; Sexton, W. J.; Siefker-Radtke, A. O.; Tollefson, M.; Tward, J.; Wright, J. L.; Dwyer, M. A.; Cassara, C. J.; Gurski, L. A.
Article Title: NCCN Guidelines® Insights: Bladder cancer, version 2.2022: Featured updates to the NCCN Guidelines
Abstract: The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer and other urinary tract cancers (upper tract tumors, urothelial carcinoma of the prostate, primary carcinoma of the urethra). These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines regarding the treatment of non-muscle-invasive bladder cancer, including how to treat in the event of a bacillus Calmette-Guérin (BCG) shortage; new roles for immune checkpoint inhibitors in non-muscle invasive, muscle-invasive, and metastatic bladder cancer; and the addition of antibody-drug conjugates for metastatic bladder cancer.
Keywords: cancer staging; neoplasm staging; neoplasm recurrence, local; pathology; bladder tumor; urinary bladder neoplasms; tumor recurrence; neoplasm invasiveness; carcinoma, transitional cell; administration, intravesical; transitional cell carcinoma; intravesical drug administration; tumor invasion; humans; human; male
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 20
Issue: 8
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2022-08-01
Start Page: 866
End Page: 878
Language: English
DOI: 10.6004/jnccn.2022.0041
PUBMED: 35948037
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 1 September 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Harry W Herr
    594 Herr
Related MSK Work